## CVX: Chevron Corporation - XLE: Energy

### Executive Summary

No thesis match: MRS_10 -0.3% below STRENGTH zone (3.0-6.0%); PEG 2.87 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($144.71)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Chevron (CVX): Assessing Valuation After Recent Share Price Weakness and Long-Term Return Strength**
- Source: Simply Wall Street | 20251221T204618 | Bullish | Relevance: 100%
- Chevron (CVX) has underperformed the market recently despite improved profits, but its long-term returns remain strong. The company is currently assessed as 14.3% undervalued with a narrative fair value of $172.33, driven by future free cash flow and strategic investments in new energy. Despite potential risks, a full analysis reveals a richer future earnings multiple may be justified.

**2. Chevron Could Raise Its Dividend Next Month - CVX Stock Looks Too Cheap**
- Source: Barchart.com | 20251221T140147 | Bullish | Relevance: 100%
- Chevron (CVX) is expected to raise its dividend by 5% next month, continuing a 38-year trend. This anticipated increase suggests the stock, currently trading at $147.75, could be undervalued by over 15% based on its historical average dividend yield, potentially reaching $170.27. Investors can either buy CVX shares directly or sell out-of-the-money put options to generate income and potentially acquire shares at a lower price.

**3. 1 Stock I'd Buy Before Chevron in 2026**
- Source: Finviz | 20251221T132000 | Neutral | Relevance: 100%
- While Chevron offers stability and a strong dividend history, ConocoPhillips presents a more attractive growth opportunity for investors looking ahead to 2026. ConocoPhillips is expanding through strategic acquisitions and significant projects like the Alaskan Willow Project, while also implementing cost reductions and asset dispositions to boost its balance sheet. Its stock is currently priced more fairly than Chevron's, making it an appealing option for growth and income-seeking investors.

**4. [Form 4] CHEVRON CORP Insider Trading Activity**
- Source: Stock Titan | 20251220T150837 | Neutral | Relevance: 100%
- Chevron Corporation's CFO, Eimear P. Bonner, reported routine equity compensation activities involving restricted stock conversions and tax withholdings. On December 17, 2025, Bonner converted restricted stock units into common stock and had shares withheld to cover tax obligations. After these transactions, Bonner's direct and indirect holdings of Chevron shares were updated, alongside her remaining restricted stock units.

**5. CFOs Speak: Straight Talk From Chevron and a Biotech Pioneer**
- Source: Bloomberg.com | 20251221T210000 | Bullish | Relevance: 100%
- This article provides a special edition of the CFO Briefing newsletter, featuring exclusive conversations with Chevron's CFO Eimear Bonner and Alnylam's CFO Jeff Poulton. They discuss their companies' outlooks for 2026 and beyond, with a focus on free cash flow targets for Chevron and their operations post-acquisition of Hess.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Mizuho | $206 | $204 | +1% |
| 2025-12-11 | B of A Securiti | $180 | $183 | -2% |
| 2025-12-01 | HSBC | $169 | $166 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Mizuho | main | Outperform |
| 2025-12-11 | B of A Securiti | main | Buy |
| 2025-12-01 | HSBC | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.86M) |
| Sells | 3 ($37.80M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 9 / 0 |

**Top Holders:**
- Vanguard Group Inc: 9.1% (+17.9%)
- State Street Corpora: 7.6% (+9.2%)
- Blackrock Inc.: 6.9% (+16.9%)
- Berkshire Hathaway, : 6.1% (0.0%)
- Geode Capital Manage: 2.2% (+18.0%)

### Key Risks

1. Heavy insider selling: $38M sold (3 transactions in 90 days).
2. Valuation risk: PEG 2.9x with declining EPS estimates leaves no margin for error.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.87 signals overvaluation risk, limited margin of safety. Forward P/E 19.8x stretched relative to 3% growth. Balance sheet: $4.7B free cash flow. Insider selling cluster ($37.8M in 90 days), potential headwind. Institutional flow bullish (9 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $301.8B |
| Beta | 0.67 |
| 52W Range | $132.04 - $168.96 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.87 |
| Forward P/E | 19.8 |
| Current P/E | 20.4 |
| YoY Growth | 2.9% |
| EPS Direction | FALLING |

### Technicals

MRS_10 stable at -0.3% (minimal 5-day change). Below STRENGTH zone by 3.3pp (needs >3.0% for momentum thesis). Below SMA200 (1.00x), long-term trend not supportive. RSI neutral at 48. OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.33% (CS: 45) | Neutral |
| RSI_14 | 48.0 | Neutral |
| MACD Histogram | -0.01 | Bearish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 0.983x | Below |
| vs SMA200 | 0.996x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $149.77
- **Stop Loss:** $144.71 (3.4% risk)
- **Target:** $154.83 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 118
- **Position Value:** $17,672.86
- **Portfolio %:** 17.67%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-30 (Est: $1.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.71 | $1.85 | +8.4% |
| 2025Q2 | $1.74 | $1.77 | +1.7% |
| 2025Q1 | $2.15 | $2.18 | +1.3% |
| 2024Q4 | $2.11 | $2.06 | -2.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*